Short answer
Antidepressants are not the only medications that can interact with ayahuasca. Its beta-carbolines temporarily inhibit MAO-A, and the experience itself can alter blood pressure, heart rate, temperature, consciousness, and coordination. Stimulants, serotonergic substances, sedatives and cardiovascular medications are among the substances that may affect the risks. There are no direct studies for most specific combinations; a universal compatibility chart applied to an individual would create false confidence.
Why ayahuasca can interact with many substances
A typical ayahuasca preparation combines a DMT-containing plant with the vine Banisteriopsis caapi, which contains beta-carbolines. It is the inhibition of MAO-A that reduces the rapid breakdown of DMT and makes it active orally. But MAO-A metabolizes not only DMT: the enzyme is associated with the metabolism of serotonin, norepinephrine, and other monoamines.
Therefore, the effect on MAO-A expands the range of potential interactions. Relevant substances include those that increase the synthesis or release of monoamines, reduce their reuptake, or change metabolism. A general article on how ayahuasca works provides a framework for understanding this mechanism.
At the same time, ayahuasca beta-carbolines are not identical to every pharmaceutical monoamine oxidase inhibitor. The selectivity, reversibility, duration and actual composition of the mixture differ. The general toxicology of MAO inhibition can be used as a cautionary guide, but not as an accurate predictor of the intensity or duration of a particular interaction.
Agents affecting monoamines
This broad group includes not only psychiatric drugs. Certain medications for coughs, pain, infections, migraines, cold symptoms or attention deficit disorders can affect serotonin or adrenergic transmission. Some names appear in clinical reference books on MAOI toxicity, but this does not mean that each of them has been studied in conjunction with ayahuasca.
Combined products are a particular problem. A "cold" remedy can contain several active substances, one of which affects cough, another constricts blood vessels, and the third reduces pain. Looking only at what a product is marketed for can mean overlooking some of its ingredients. The category on the package does not describe the pharmacology of all the components.
The interaction with antidepressants is discussed in more detail separately in the material ayahuasca and antidepressants. Any agent that alters monoamine transmission requires accurate identification and professional evaluation.
Blood pressure and heart rhythm
In controlled studies, ayahuasca may temporarily increase blood pressure and heart rate. In a healthy participant selected for a study, a moderate change in these measurements is not necessarily a complication. However, drugs that raise or lower blood pressure, affect rhythm, constrict blood vessels, or alter the response to exercise can make the overall response less predictable.
The concern extends beyond high readings. Fluctuations, dizziness, fainting and heart rhythm disturbances are also possible, sometimes alongside vomiting and dehydration. A single measurement taken at home before a ceremony does not describe the body's ability to adapt to acute changes.
For people with cardiovascular conditions or a history of fainting, general information cannot replace an individual assessment. Information about increased risk factors explains why not only the name of the drug is important, but also the reason for which it is prescribed.
Sedatives, painkillers and consciousness
Drugs that cause drowsiness, reduce coordination, or suppress breathing create another type of uncertainty. Ayahuasca itself alters consciousness and can induce vomiting. Additional sedation can make it harder to monitor someone, keep them in a safe position and notice promptly if their condition worsens.
Not all painkillers work the same. Some affect inflammation primarily, some affect the opioid system, and some have additional serotonin effects. Therefore, the word "analgesic" is as inaccurate as "nerve medicine". Assessment requires the active ingredient, not a general household label.
A separate risk arises when a sedative is used after the onset of an adverse reaction without clinical evaluation. Symptoms can have several causes, and adding another substance without assessment can complicate the clinical picture. An informational article cannot determine the appropriate treatment for an acute reaction.
Seizure threshold and mental stability
Some drugs can affect the seizure threshold, while others are prescribed specifically for seizure control or mood stabilization. A sudden change in such therapy can itself create a risk. At the same time, reports of seizures in the context of psychedelics often contain incomplete data on concomitant substances, medical history, and product composition.
A similar logic applies to antipsychotics and mood stabilizers. A person taking these medications may have a condition that makes intense changes in perception and sleep particularly concerning. Even if the drug weakens some of the subjective effects, it does not turn the combination into a predictable one.
A universal table would not be able to simultaneously take into account pharmacology, the stability of the underlying condition and the consequences of changing treatment. This is where a personal assessment is more important than a list of names.
Supplements, herbal products and over-the-counter products
People often don't call supplements "medicines," even though they may contain pharmacologically active substances. Products for mood, sleep, energy, weight loss, or exercise sometimes affect monoamines, blood pressure, or blood clotting. The multi-component composition complicates the assessment even more.
Plant origin does not imply a weak effect. Ayahuasca itself is an example of a herbal combination with a pronounced pharmacological effect. The division into "natural" and "chemical" does not predict interaction; the substances involved, the amount and timing of use, and the person’s health all matter.
Remedies for coughs, colds, allergies, insomnia or pain can be bought without a consultation, but this does not make them irrelevant to a complete medication history. The evaluation should include everything that was used regularly or recently.
How to list your medications and supplements
A clear list is more useful than trying to look up every possible combination online yourself. Copy the names from the packaging or your medical record, including the active ingredients and formulations. Separately, it is worth writing down supplements, combined products and medications taken occasionally that are easy to forget.
- the exact name of each active substance and dosage form;
- the usual dosing schedule and time of the last dose, if known, without changing treatment on your own;
- the reason for the prescription and the stability of the current state;
- supplements, energy products, cold, cough, pain and sleep remedies;
- previous adverse reactions, fainting, convulsions or rhythm disturbances.
Such a list does not provide an automatic answer, but allows the doctor or clinical pharmacist to check the mechanisms, duration of action and the risk of changing the main therapy. A complete written list is more reliable than memory alone.
Symptoms that require immediate evaluation
Acute interactions may have nonspecific manifestations. High fever, convulsions, fainting, chest pain, severe shortness of breath, extreme agitation, confusion, muscle stiffness, or sudden deterioration should not be attributed to an "intense process" alone. They need immediate professional evaluation.
For medical professionals, the packaging or exact names of all substances, when they were taken and how symptoms developed are important. Do not hide supplements or products that seem insignificant. An overview of the risks of ayahuasca and the limits of the evidence helps to understand why early recognition is more important than trying to self-diagnose the syndrome.
Why compatibility tables are misleading
The table makes a complex conclusion appear binary: green or red, yes or no. But there is no direct controlled study for most combinations. The color would then reflect the author's guess, not the measured risk.
In addition, one drug can have several mechanisms, and a person can have several medications and conditions at the same time. Even a correct conclusion for one substance does not describe the combination with others. Well-written material shows the level of evidence and how far the findings can be applied, rather than masking uncertainty with a simple icon.
Two ways in which substances can affect each other
Pharmacodynamic interaction means that the effects are superimposed at the level of bodily functions. Two substances can simultaneously increase serotonin activity, blood pressure, agitation or drowsiness, even if they do not alter each other’s concentration in the body. In such a situation, the risk arises from the sum or conflict of physiological effects.
Pharmacokinetic interactions alter absorption, metabolism, or excretion. One substance can slow down the transformation of another, prolong its presence or change the formation of an active metabolite. For ayahuasca, the main known example is the inhibition of DMT breakdown by beta-carbolines, but other pathways are much less well studied.
Both types can act simultaneously, and external symptoms do not show which mechanism prevails. This is why a short answer based on a single entry in a reference guide is often insufficient. Assessment requires a full list of substances, the timing of their use, medical history and the person’s current condition. Having no noticeable symptoms on a previous occasion does not guarantee the same outcome next time.
What the evidence shows and what remains uncertain
Ayahuasca beta-carbolines have been shown to inhibit MAO-A, and the mixture itself can acutely alter consciousness and cardiovascular function. Clinical toxicology describes how MAO inhibition can interact with substances that enhance monoamine activity. Reviews of adverse events confirm the presence of physical and psychological reactions of varying severity.
Direct studies of most specific pairs, standardization of composition, and data for people with comorbidities or complex therapy are lacking. A systematic review of the interactions of classic psychedelics found only one study of ayahuasca. Consequently, many warnings are based on mechanism and general toxicology; they warrant caution but do not give a precise estimate of individual risk.